ARCHIVES

NIH Plans Consensus Conference On Ovarian Cancer April 5-7

This article is from The Cancer Letter archive.

Vol. 20 No. 04 | January 28, 1994

Download PDF Visit The Full Archive

Related Articles

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

UC Davis Becomes 41st Center to Earn NCI Comprehensive Designation

March 16, 2012

Greatest Need Of Cancer Care Givers: “Will to Work Together,” ACCC President Anderson Says

August 15, 1986

Mass. Requires Coverage of Routine Patient Care In Clinical Trials

September 6, 2002

Chemical, Viral Carcinogenesis Should Not Be Separated: Shimkin

July 14, 1978

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012